Connor Clark & Lunn Investment Management Ltd. Buys 44,173 Shares of Kenvue Inc. $KVUE

Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Kenvue Inc. (NYSE:KVUE) by 152.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 73,203 shares of the company’s stock after buying an additional 44,173 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Kenvue were worth $1,532,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Renaissance Capital LLC lifted its stake in Kenvue by 8.3% in the 2nd quarter. Renaissance Capital LLC now owns 629,177 shares of the company’s stock worth $13,169,000 after purchasing an additional 48,267 shares in the last quarter. Farther Finance Advisors LLC increased its position in Kenvue by 80.7% during the second quarter. Farther Finance Advisors LLC now owns 36,196 shares of the company’s stock valued at $758,000 after acquiring an additional 16,164 shares during the last quarter. Arlington Partners LLC purchased a new stake in Kenvue in the 2nd quarter worth about $2,110,000. Cornell Pochily Investment Advisors Inc. raised its holdings in shares of Kenvue by 144.6% in the second quarter. Cornell Pochily Investment Advisors Inc. now owns 33,173 shares of the company’s stock worth $694,000 after buying an additional 19,609 shares during the period. Finally, IFP Advisors Inc lifted its stake in shares of Kenvue by 25.3% during the 1st quarter. IFP Advisors Inc now owns 15,278 shares of the company’s stock worth $369,000 after acquiring an additional 3,081 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on KVUE. JPMorgan Chase & Co. lowered their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, October 10th. The Goldman Sachs Group dropped their target price on shares of Kenvue from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft set a $18.00 price target on Kenvue in a report on Friday, October 24th. Redburn Partners set a $22.00 price objective on Kenvue in a report on Friday, September 26th. Finally, Zacks Research raised Kenvue to a “strong sell” rating in a research report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $20.23.

Kenvue Price Performance

KVUE stock opened at $16.68 on Monday. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The firm has a market capitalization of $31.95 billion, a PE ratio of 22.23, a price-to-earnings-growth ratio of 2.43 and a beta of 0.71. The business has a 50 day simple moving average of $16.42 and a 200-day simple moving average of $20.03.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business’s revenue for the quarter was down 3.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th will be paid a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, November 12th. This represents a $0.83 annualized dividend and a dividend yield of 5.0%. Kenvue’s payout ratio is currently 110.67%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.